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CI: 0.333-1.068; p0.07) which approached significance. Also, palavizumab users
incurred significantly lower all-cause costs compared to non-users ($6,206 vs.
$7,238; p0.0001). In the 2010-2011 season, 317 palavizumab users and 317 non-
users were identified. palavizumab users had a similar effect on the likelihood of
diagnoses of pneumonia (OR: 0.595; 95% CI: 0.278-1.272; p0.18) and bronchiolitis
(OR: 0.621; 95% CI: 0.346-1.112; p0.108). Also, palavizumab users incurred signifi-
cantly lower all-cause costs compared to non-users ($5,761 vs. $6,562; p0.0001).
CONCLUSIONS: When used in accordance with the 2009 American Academy of
Pediatrics Policy Statement, palavizumab appeared to reduce episodes of pneumo-
nia and bronchiolitis among children enough to reduce total program costs even
though the reductions were not statistically significant.
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OBJECTIVES: Majority of the existing research on medication adherence has fo-
cused on secondary non-adherence,with only a few studies onprimarymedication
non-adherence (PMN). PMN is defined as the failure of a patient to fill a new med-
ication prescribed by the healthcare provider. Themain objective of this study was
to formulate a comprehensive approach to capture PMN using commercial claims
datasets and to test it among pediatric population with asthma. METHODS: This
study utilized a retrospective longitudinal cohort study design involving Medicaid
claims data. The study population consisted of asthmapatients 16 years or younger
continuously enrolled for the entire study period. The patients were deemed as
PMN cases if they were found to have presence of only one claim for asthma
controller medication indicating failure to any subsequent refills. A multiple logis-
tic regression model was built to assess the predicting factors of PMN. RESULTS:
There were 8892 patients who met the inclusion criteria for this study. Of the total
8,892 patients 43% (3,846) patients stopped filling their prescription after the initial
one. African Americans (OR 0.893; CI 0.809- 0.986), other minorities (OR 0.842;
CI 0.742- 0.954), were less likely to have PMN compared to the Caucasians. Num-
ber of comorbidities decreased the odds of having PMN (OR0.801; CI 0.73- 0.879)
while fees-for-service plans (OR 1.18; CI 1.072- 1.298) increased. CONCLUSIONS:
The study successfully identified patients that could be attributed to PMN using a
population based claims dataset. The rate of PMN identified in this analysis is
alarmingly higher than any previous study. This could be explained due to two
factors: 1) The unique methodology applied in this study; 2) The study population
being drawn from Medicaid beneficiaries who are primarily belonging to low in-
come groups. Future research is warranted to address the issue of PMN.
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OBJECTIVES: Inhaled corticosteroids (ICS) are widely used in the management of
chronic obstructive pulmonary disease (COPD). Prior research suggests that COPD
patients’ access to ICS may vary by ethnicity. The objectives of the study were to
determine if there is a difference in the proportion of Hispanic and non-Hispanic
White patients taking ICS for COPD and to determine the independent predictors of
taking an ICS prescription in COPD patients.METHODS: The US Medical Expendi-
ture Panel Survey (MEPS) 2007 dataset was utilized to compare ICS prescription
patterns among patients with COPD. The sample size was restricted to Hispanic
and non-HispanicWhite patients with ICD-9CM codes for COPD between January 1
and December 31, 2007. Proportion of patients receiving ICS prescriptions within
the defined timeframewas compared by ethnicity in chi-square analysis. Multivar-
iate logistic regression was used to determine significant predictors of receiving an
ICS prescription. RESULTS: Among 1057 COPD patients included in the analysis,
16% were Hispanics, 58.5% females, and the mean age of the study population was
45.824.5. ICS were prescribed for 5.2% of Hispanic and 17.2% of non-Hispanic White
patients (p0.02). Non-Hispanic White patients with COPD had 9.37 (95% CI: 1.39;
73.28) higher odds of receiving ICS prescription thanHispanic patients independent of
age, marital status, education, smoking status, and health insurance. Among other
risk factors, only smoking was predictive of receiving a prescription for ICS (OR1.80;
95% CI: 1.03; 3.11), independent of other factors. CONCLUSIONS: Hispanic COPD
patients had substantially lower odds of receiving an ICS prescription. This
disparity in ICS prescription patterns may translate into suboptimal COPDman-
agement, a higher rate of exacerbations, and higher healthcare costs in this
growing minority population. The differences and potential disparities in ICS
use between Hispanic and non-Hispanic White COPD patients warrant further
investigation.
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OBJECTIVES: The prevalence, policies and disease control programs for Asthma
vary considerable across the country. The aim of this study is the evaluation of
inequalities in utilization of healthcare resources in Asthma diagnosed population
by using a national household survey.METHODS:We used data from 2008 Health
Supplement of the National Household Sample Survey (PNAD) conducted by Bra-
zilian Institute of Geography and Statistics (391,868 subjects). The study population
was subjects aged14 yearswith self-reportedmedical diagnosed asthma or bron-
chitis, comprising 7,509 subjects. The outcomes were presence of hospital admis-
sion and physician visit in the last year, and use of chronic medication. The out-
comes were analyzed by socio-demographic variables. Statistical analysis
comprised logistic regression for association measures, and 2 and F test to test
results independence, being significant p0.005. All analysis considered complex
plan sampling. RESULTS: In one year, among the diagnosed asthma and bronchitis
patients, 84.0% had physician visit and 12.6% had hospital admission. Also, 16%
reported use of chronic medication. The frequency of hospital admission de-
creased with the increasing of age (OR: 0.85 p0.001) and of household head edu-
cational level (OR: 0.88 p0.001). Also, hospital admission varied significantly
across the Brazilian regions (16.0% in North and Northeast to 9.8% in South
p0.001). The presence of physician visit and use of chronic medication increased
with the household educational level (OR: 1.32 p0.001 and OR:1.34 p0.001, re-
spectively) and decreased with the household overcrowding (person/bedroom)
(OR:0.89 andOR: 0.88, respectively). Furthermore, physician visit and use of chronic
medication were higher in more developed regions and white household head.
CONCLUSIONS: Patients with greater use of physician visit and medication had
lower frequencies of hospital admission. Considering the regional disparities, it is
imperative to implement effective national asthma management approaches
aimed at the appropriate target populations.
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OBJECTIVES: To compare characteristics of patients with diagnosed allergic rhini-
tis (AR) by quartiles of health care costs.METHODS: Patients 12-64 years of agewith
2 AR diagnoses or 1 diagnosis and 1 AR-related prescription claim continu-
ously eligible for 12 months before and 12 months after an AR diagnosis (1/1/2008-
3/31/2011) were identified from a privately-insured claims database
(N14,000,000). The index date was defined as the most recent AR diagnosis date
meeting the eligibility criteria, baseline period as 12 months before, and study
period as 12 months after the index date. Descriptive analyses compared demo-
graphic characteristics, co-morbidities, healthcare resource utilization and costs
(inflated to 2010 dollars) among patients in different quartiles of study period
health care costs. RESULTS: A total of 146,597 patients met the inclusion criteria.
Health care costs per patient ranged from $0-$1,118 for the lowest quartile(Q1) to
$6,349-$1,059,699 for the top quartile(Q4). Q4 patients were significantly(p0.05)
older (age 46 vs. 44[Q3], 40[Q2], 36[Q1]), had significantly higher proportion of
women (66.5% vs. 62.6%, 56.7%, 43.9%), hadmore co-morbid conditions (e.g., sinus-
itis, asthma, depression, sleep apnea), and used significantly more medications
(13.4 vs. 8.8, 6.1, 3.7) at baseline than patients in lower quartiles. During the study
period, Q4 patients had significantly higher rates of inpatient visits (26.7% vs. 3.4%,
1.2%, 0.6%), emergency department visits, outpatient/other days, and prescription
drug use, as well as higher healthcare costs ($19,519 vs. $4,186, $1,798, $544), and
they accounted for 75% of health care costs among AR patients. Additionally, Q4
patients had the highest AR-related costs ($662 vs. $521, $345, $155) and accounted
for 40% of AR-related costs among AR patients. CONCLUSIONS: Health care costs
for patients with AR were highly variable, with patients in the top quartile respon-
sible for themajority of costs. High cost AR patients were older, had higher propor-
tions of co-morbid conditions and higher health care resource utilization than
lower cost AR patients.
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OBJECTIVES: To assess the awareness amongAgateworker about silicosis, preven-
tative methods, and usage of preventative methods and factors affecting the their
usage. METHODS: It is a cross-sectional study among agate workers in Khambat
region of Gujarat State in India. The Khambat region is known for the household
agate industry, and many of workers are poorly educated and are at risk of deadly
Silicosis disease due to exposure of silica dust generated by agate grinding. This
study was conducted to assess the awareness level about silicosis, awareness
about the protective methods, worker attitude toward health, and prevalence of
actual use of protective methods to avoid silica exposure. The study was based on
questionnaire based structured interviews of 82 agate workers. RESULTS: Analysis
of the results suggests that majority of the workers (55%) were aware about the
silicosis, harmful effect of silica-dust exposure (72%), protective methods to avoid
silica-dust exposure (80%), but onlyminority of theworkers (22%) are actually using
the protective methods. Further investigation reveals the more educated workers
are more likely to use the easily available protective methods than the less edu-
cated or illiterate workers, though the awareness about of the silicosis and protec-
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tive methods was same. There was only 9% of the illiterate workers were using
while the usage compliance increased to 28%. Gender based analysis suggests that
the women workers were less aware about silicosis disease and less educated -
these could be reasons for women workers for less likely use protective methods.
CONCLUSIONS: Awareness is important for the health safety, but the understand-
ing and education level of workers is key factors, these data suggest that not just
the awareness, but also the education level of workers plays a significant role in
compliance toward the usage of protective methods.
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OBJECTIVES: To examine characteristics of US patients with emergency depart-
ment (ED) visits or hospitalization for anaphylaxis, and the cost drivers of these
visits. METHODS: This retrospective study utilized the MarketScan® claims data-
bases to identify patients enrolled in employer-sponsored health plans and visited
EDs or hospital with anaphylaxis between 2002 and 2008. Patients had to have 1
year continuous health coverage pre- and post-index (first observed event date)
and were excluded if immunocompromised, had pre-index cancer diagnoses or
sepsis at index. Descriptive statistics were evaluated for patient characteristics
during the pre-index period and for costs of index events. Multivariate analyses
were conducted examining cost drivers of index events. RESULTS: A total of 11,972
patients were identified (mean age 42, children 19%; female 59%; Northeast 12%;
triggers: unknown cause 66%, food 20%, venom 8%,medicine 6%), and themajority
of events occurred in ED (78%). Compared to adult patients, children (18 years)
weremore oftenmale (56 vs. 38%), and had different pre-index comorbidities (4 vs.
1 of 5 most prevalent comorbidities were allergy-related). Mean index event costs
were $1553  1705 for ED visits and $14262  36108 for hospital stays. Unadjusted
ED costs for children did not differ across triggers (P0.78), but hospitalization costs
did (P0.001). For adults both ED and hospital event costs differed by trigger
(P0.001). In multivariable analyses unknown and venom triggered event costs for
adults were 1.13 (P0.03) and 1.34 (P0.01) times greater than those for children
regardless of place of service. Overall, pre-index epinephrine auto-injection device
(EAID) fill was associated with lower event cost (0.89 times; 95% CI 0.83-0.95).
CONCLUSIONS: This study found significant differences in clinical characteristics
and costs by age group, trigger, and treatment setting among patients with ana-
phylaxis. Pre-index EAID fill may be associated with lower ED/hospitalization cost,
but needs confirmation in future studies.
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OBJECTIVES: To evaluate the prevalence of smoking behavior among university
students in Pakistan. METHODS: The cross-sectional study was conducted in two
provinces, KPK and Punjab of Pakistan. Only smoking students’ population of the
universities were included. Six univerties were included in the study from four
cities of these two provinces. These cities were selected for study as they can
provide ethnic mix of student response residing in these areas. A total of 750
questionnaires were administered out of which 524 questionnaire were received
giving the response rate of 69.8% of which 419 were males and 105 were females
from different universities. RESULTS: Among 524 respondents, 419 were male and
105 were female students. Students were recruited regarding socio-demographic
factors, smoking history of students, their families, friends and class fellows/room-
mates and place of residence. Students having family history of smoking (23.87% of
males; 34.29% of females), roommates (21% of males; 5.71% females), close friends
(57.51% of males; 54.28% of females) and class fellows (37.23% of males; F36.19%
of females) were significantly associatedwith smoking. Public health awareness on
media and warnings printed on tobacco products (cigarettes and flavors) had no
statistically significant association with respondents’ continuation, and cessation
status. CONCLUSIONS: The Shisha smokers thought that shisha smoking is less
harmful than cigarette smoking. It is suggested that the factors which influence
Pakistani students to smoke may not be significantly different from counties with
a broader evidence base. There is a need to adopt the provisions of the Framework
Convention on Tobacco Control (FCTC) with respect to smoke free places, public
education and treatment for tobacco cessation. Steps should betaken by the gov-
ernment to increase people’s awareness on the health hazards of tobacco smoking
(Shisha and cigerretes) and to prevent young generation from smoking.
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OBJECTIVES: The study evaluated predictors of willingness to quit smoking among
cigarette smokers in India.METHODS: A cross-sectional study using a self-admin-
istered questionnaire was conducted in a cohort of adults aged 18 years in India.
The outcome variable, willingness to quit smoking was dichotomized. Indepen-
dent variables included socio-demographic characteristics, behavioral and envi-
ronmental determinants of smoking like past quit attempts, smoking status of
peers and social pressure. SAS(9.2v) was used to determine frequencies and chi-
square analyses followed by Fisher’s exact test and stepwise logistic regression to
determine predictors of willingness to quit. RESULTS: The study cohort consisted
of 456 smokers (response rate 41.3%) among which 253 (54%) were willing to quit
smoking. Almost 60% of smokers willing to quit weremales, 53.3% had a bachelor’s
degree, 81.4% were married, 46.6% belonged to the $10,000/yr-$20,000/yr in-
come category and 43.8% to 30-39 years age category. More than 50% had non-
smoking peers. Majority (88.8%) had very low addiction levels and 40% attempted
to quit at least once in their lifetime. Bivariate analysis indicated that age (p0.002),
education (p0.009), siblings’ smoking status (p0.0001), number of smoking
friends (p0.0001), age of initiation (p0.03), past quit attempts (p0.0001) and
social pressure (p0.006) were associated with willingness to quit. Fisher’s exact
test demonstrated that past quit attempts of 3 (p0.0001; OR2.55; 95%CI1.59-
4.06) or 4 (p0.0001; OR33.14; 95%CI7.87–139.63), close friends (p0.002;
OR1.86; 95%CI1.24-2.75), siblings being non-smokers (p0.001; OR3.05;
95%CI2.07–4.45), and few smoking friends (p0.001; OR2.81; 95%CI1.73–4.56)
were predictors of willingness to quit. Logistic regression indicated that smokers
aged 40-49 (p0.02; OR2.06; 95%CI1.13-3.75), 50-59 years (p0.02; OR9.43;
95%CI1.13-79.87), and faced with social pressure (p0.02; OR2.05; 95%CI1.07-
3.9) were willing to quit. CONCLUSIONS: Research on interventions targeting
smokers willing to quit such as those facing social pressure or older smokers,
would prove beneficial for them to permanently quit smoking.
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OBJECTIVES: The objectives of this study were to examine the trends of child
obesity and changes in BMI over time and to analyze the effect of child obesity on
asthma.METHODS: The Early Childhood Longitudinal Study Kindergarten Class of
1998-99 (ECLS-K) data from the U.S. Department of Education identified 14,188
children in the 3rd grade who were followed through 3 waves (3rd, 5th and 8th
grade). Dichotomized weight group (obese vs. non-obese), based on body mass
index (BMI) using the 2000 sex-specific CDC growth charts for the United States,
was included in the sampleweight-adjusted cross-sectional logistic analyses and a
panel fixed effects (FE) model for having asthma. RESULTS:We detected a gradual
increase in the mean BMI and prevalence of obesity over time. Significant differ-
enceswere observed for obesity and asthma rate amongmale and female groups in
the 3rd grade (p0.05). In cross-sectional analyses, obesity and gender were signif-
icantly associated with having asthma for each grade level while adjusting for
other demographic covariates (all p0.05), indicating that children who are obese
or male were more likely to have asthma. Approximately 70% of children stayed
within the same weight category from 3rd to 8th grade. FE model showed a signif-
icant time effect where odds of having asthma increased 3.31 times from 3rd to 5th
grade while controlling for child obesity (95% CI: 2.89-3.80). Child obesity and the
interaction term between time effect and child obesity had no significant effect on
asthma although the sign of estimate for child obesity indicated an increase in risk
for asthma. CONCLUSIONS: We found a risk association between child obesity
and asthma in cross-sectional analyses but the effect of obesity on asthma was
not significant in a panel data FE model. Future research with a model using an
instrumental variable is warranted to control for endogeneity associated with
obesity.
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OBJECTIVES: Chronic Obstructive Pulmonary Disease (COPD) is a major public
health issue and a leading cause of morbidity and mortality in the United States.
High frequency of exacerbations can lead to rapid decline in lung function in COPD
patients. The study objective was to evaluate 30-day readmission rates among
COPD patients who received arformoterol, a nebulized long-acting beta agonist, or
nebulized short-acting beta agonists (neb-SABA) during an inpatient stay.
METHODS: Data from the Premier Database, a US nationally representative hospi-
tal database, were used. The study included adult inpatients aged 40 and older,
discharged between January 2006 and March 2010, having a principal diagnosis
code for COPD (ICD-9-CM 491.xx, 492.xx, 496) or secondary COPD diagnosis with a
principal respiratory diagnosis. Patients receiving arformoterol daily on 80% of
days following initiation were compared to patients receiving only neb-SABA dur-
ing hospitalization. Arformoterol patients were matched 1:2 with Neb-SABA pa-
tients on age, gender, severity of illness, and principal/secondary COPD diagnosis.
Chi-square tests were used to evaluate differences in unadjusted readmission
rates. Multivariate logistic regression was performed, adjusting for age, gender,
race, admission type, severity, principal/secondary COPD diagnosis, use of other
respiratory drugs and respiratory therapy, oxygen use, and hospital size and teach-
ing status. RESULTS: The final sample included 812 arformoterol patients and 1651
Neb-SABA patients who had not died during the initial COPD visit. ICU use, which
was not a match criterion, was greater among arformoterol patients (35.5% vs.
19.9%, p0.0001), possibly indicating greater disease burden. Unadjusted readmis-
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